PMID- 27061215 OWN - NLM STAT- MEDLINE DCOM- 20180214 LR - 20210103 IS - 1097-0347 (Electronic) IS - 1043-3074 (Print) IS - 1043-3074 (Linking) VI - 38 IP - 8 DP - 2016 Aug TI - Pools of programmed death-ligand within the oral cavity tumor microenvironment: Variable alteration by targeted therapies. PG - 1176-86 LID - 10.1002/hed.24269 [doi] AB - BACKGROUND: Enhanced understanding of programmed death-ligand (PD-L) expression in oral cancer is important for establishing rational combinations of emerging immune checkpoint and molecular targeted therapies. METHODS: We assessed PD-L and interferon (IFN) expression in immunogenic murine oral cancer-1 (MOC1) and poorly immunogenic MOC2 cell models after treatment with mammalian target of rapamycin (mTOR) and MEK1/2 small molecule inhibitors in vitro and in vivo. RESULTS: PD-L1 but not PD-L2 is expressed on MOC1 and 2 cells and is type I and II IFN-dependent. PD-L1 is differentially expressed on cancer and endothelial cells and infiltrating myeloid-derived suppressor cells, macrophages, and regulatory T cells (Tregs) in highly and poorly immunogenic tumors. PD-L1 expression is variably altered after treatment with inhibitors in vivo, with an imperfect relationship to alterations in IFN levels in the tumor microenvironment. CONCLUSION: PD-L1 expressed on cancer and infiltrating immune cells is variably altered by targeted therapies and may, in part, reflect changes in tumor IFN. (c) 2016 Wiley Periodicals, Inc. Head Neck 38:1176-1186, 2016. CI - (c) 2016 Wiley Periodicals, Inc. FAU - Shah, Sujay AU - Shah S AD - Tumor Biology Section, Head and Neck Surgery Branch, National Institutes of Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland. FAU - Caruso, Andria AU - Caruso A AD - Department of Otolaryngology-Head and Neck Surgery, Walter Reed National Military Medical Center, Bethesda, Maryland. FAU - Cash, Harrison AU - Cash H AD - Tumor Biology Section, Head and Neck Surgery Branch, National Institutes of Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland. FAU - Waes, Carter Van AU - Waes CV AD - Tumor Biology Section, Head and Neck Surgery Branch, National Institutes of Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland. FAU - Allen, Clint T AU - Allen CT AD - Tumor Biology Section, Head and Neck Surgery Branch, National Institutes of Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland. AD - Department of Otolaryngology - Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland. LA - eng GR - ZIA DC000087-01/Intramural NIH HHS/United States PT - Comparative Study PT - Journal Article PT - Research Support, N.I.H., Intramural DEP - 20160409 PL - United States TA - Head Neck JT - Head & neck JID - 8902541 RN - 0 (Programmed Cell Death 1 Receptor) RN - 9008-11-1 (Interferons) SB - IM MH - Animals MH - Disease Models, Animal MH - Female MH - Flow Cytometry MH - Gene Expression Regulation, Neoplastic/*drug effects MH - Humans MH - Immunohistochemistry MH - Interferons/*pharmacology MH - Mice MH - Mice, Inbred C57BL MH - Molecular Targeted Therapy/*methods MH - Mouth Neoplasms/drug therapy/*genetics/pathology MH - Polymerase Chain Reaction/methods MH - Programmed Cell Death 1 Receptor/drug effects/*genetics MH - Random Allocation MH - Tumor Cells, Cultured MH - Tumor Microenvironment/*drug effects/genetics PMC - PMC6669909 MID - NIHMS1042884 OTO - NOTNLM OT - interferon OT - oral cancer OT - programmed death OT - targeted therapy EDAT- 2016/04/12 06:00 MHDA- 2018/02/15 06:00 PMCR- 2019/08/01 CRDT- 2016/04/11 06:00 PHST- 2015/09/13 00:00 [accepted] PHST- 2016/04/11 06:00 [entrez] PHST- 2016/04/12 06:00 [pubmed] PHST- 2018/02/15 06:00 [medline] PHST- 2019/08/01 00:00 [pmc-release] AID - 10.1002/hed.24269 [doi] PST - ppublish SO - Head Neck. 2016 Aug;38(8):1176-86. doi: 10.1002/hed.24269. Epub 2016 Apr 9.